Business

Celularity licenses biomaterials portfolio for up to $35 million

Mar 10, 2026 - 13:00
 3
Celularity licenses biomaterials portfolio for up to $35 million
Read More

Related Posts

Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Atea Pharmaceuticals Issues Statement Regarding Directo...

Mar 21, 2025  3

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025  9

Airlines issue travel waivers due to London's Heathrow Airport shutdown

Airlines issue travel waivers due to London's Heathrow ...

Mar 21, 2025  0

Dream Finders Homes director Lovett sells $2.65 million in stock

Dream Finders Homes director Lovett sells $2.65 million...

Mar 21, 2025  0

Elon Musk reassures Tesla workers with all-hands meeting, admits it 'feels like Armageddon'

Elon Musk reassures Tesla workers with all-hands meetin...

Mar 21, 2025  13

ZipRecruiter SVP Bartolome Lora sells $12,861 in shares

ZipRecruiter SVP Bartolome Lora sells $12,861 in shares

Mar 21, 2025  2